Medicine & Life Sciences
HIV Protease Inhibitors
100%
Antiviral Agents
58%
PD 178390
57%
Urography
53%
Kidney Pelvis
37%
Contrast Media
33%
HIV
31%
Pyrans
31%
Lead
31%
Ureteroscopy
31%
Infant Formula
29%
Coronavirus
28%
Ureter
28%
Therapeutic Index
28%
HIV Protease
25%
aniline
23%
Pharmacokinetics
23%
Urinary Tract
22%
Radiology
22%
Tomography
21%
Pandemics
20%
Thiophenes
18%
Biological Availability
17%
Magnetic Resonance Imaging
15%
Neoplasms
14%
Pain
13%
Drug Industry
13%
Health
13%
Enzymes
12%
Kidney
12%
HIV-1
11%
Interventional Radiology
11%
Peptidomimetics
11%
Workforce
11%
Angiography
11%
Ultrasonography
10%
Magnetic Resonance Spectroscopy
10%
Urothelium
9%
Peptide Hydrolases
9%
X-Rays
9%
Ambulatory Care
9%
Cytochrome P-450 CYP3A
8%
Hydroxyl Radical
8%
Animal Models
8%
Abdominal Pain
8%
Hematuria
8%
Radiation Exposure
8%
Maintenance
8%
Physicians
7%
Appointments and Schedules
7%
Chemical Compounds
HIV Protease Inhibitor
50%
Pharmacokinetics
34%
Bioavailability
33%
Hydroxymethyl Group
30%
Peptidomimetic
27%
Strain
26%
Kd
23%
Alkyl Group
22%
Reaction Half Life
21%
Substitution Reaction
19%
Aniline
16%
Crystal Structure
15%
Pharmaceutical Industry
11%
Thiophene
10%
Protease Inhibitor
9%
Time
8%
Sulfonamide
7%
Sulfonate
7%
Cyclic Structure
6%
Molecular Modeling
6%
Safety
6%